help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on January 20, 2005
Endocrinology, doi:10.1210/en.2004-1605
A more recent version of this article appeared on May 1, 2005
This Article
Right arrow Author Manuscript (PDF)
Right arrow All Versions of this Article:
146/5/2424    most recent
Author Manuscript (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by YUE, L.
Right arrow Articles by DAS, S. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by YUE, L.
Right arrow Articles by DAS, S. K.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*Nucleotide
*Protein*UniGene
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*PROGESTERONE

Submitted on December 13, 2004
Accepted on January 14, 2005

Cyclin G1 and cyclin G2 are expressed in the periimplantation mouse uterus in a cell-specific and progesterone-dependent manner: Evidence for aberrant regulation with Hoxa-10 deficiency

LIMIN YUE, TAKIKO DAIKOKU, XIAONAN HOU, MEILING LI, HAIBIN WANG, HIROSHI NOJI MA, SUDHANSU K. DEY, and SANJOY K. DAS*

Division of Reproductive and Developmental Biology, Departments of Pediatrics (L.Y., T.D., X.H., H.W., M.L., Su.K.D., Sa.K.D.), Cancer Biology (X.H., M.L., Sa.K.D.), Cell & Developmental Biology (L.Y., T.D., H.W., Su.K.D.) and Pharmacology (L.Y., T.D., H.W., Su.K.D.), Vanderbilt University Medical Center, Nashville, TN 37232, and Department of Molecular Genetics (H.N.), Research Institute for Microbial Diseases, Osaka University, Osaka, Japan

* To whom correspondence should be addressed. E-mail: sanjoy.das{at}vanderbilt.edu.

Since uterine cell-specific proliferation, differentiation and apoptosis are differentially regulated during the periimplantation period, we speculated that negative cell cycle regulators are also operative in the uterus during this period. This prompted us to examine the roles of two negative growth regulatory genes cyclin G1 and cyclin G2 in the periimplantation mouse uterus. We show that cyclin G1 and cyclin G2 genes are differentially regulated in the uterus during this period (days 1-8 of pregnancy) in a spatiotemporal manner. The results suggest that cyclin G1 is primarily associated with epithelial cell differentiation before implantation and stromal cell proliferation and differentiation during decidualization, while cyclin G2 is associated with terminal differentiation and apoptosis of the luminal epithelial and stromal cells at the site of blastocyst following implantation. Pharmacological and genetic studies provide evidence that the expression of cyclin G1, not cyclin G2, is regulated by progesterone via its nuclear receptor. Furthermore, the expression of these genes are aberrantly upregulated in Hoxa-10 mutant uteri, suggesting that cyclin G1 and cyclin G2 genes act as downstream targets of Hoxa-10 and negatively impact uterine cell proliferation. Collectively, our present and previous studies suggest that negative cell cycle regulators collaborate with growth promoting regulators in regulating uterine cell specific proliferation, differentiation and apoptosis relevant to implantation and decidualization.




This article has been cited by other articles:


Home page
Molecular Cancer TherapeuticsHome page
X.-F. Le, A. S. Arachchige-Don, W. Mao, M. C. Horne, and R. C. Bast Jr.
Roles of human epidermal growth factor receptor 2, c-jun NH2-terminal kinase, phosphoinositide 3-kinase, and p70 S6 kinase pathways in regulation of cyclin G2 expression in human breast cancer cells
Mol. Cancer Ther., November 1, 2007; 6(11): 2843 - 2857.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
S. Ray, X. Hou, H.-E. Zhou, H. Wang, and S. K. Das
Bip Is a Molecular Link between the Phase I and Phase II Estrogenic Responses in Uterus
Mol. Endocrinol., August 1, 2006; 20(8): 1825 - 1837.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2005 by The Endocrine Society